Corona virus disease. COVID19, virus identified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged between 18-95 years Patients Approved for Covirus 19 by Laboratory Methods Patients with mild to moderate respiratory distress Hospitalization in the ICU
Exclusion criteria
Exclusion criteria: Patients undergoing other clinical trials Patients with underlying diseases including diabetes, heart disease, respiratory disease, cancer patients and patients undergoing chemotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary Condition. Timepoint: At the beginning of the study and 1 day and 2 days, 4 days, 7 days and 14 days after the start of the study. Method of measurement: CT scan.;Expression of nucleic acid of virus. Timepoint: At the beginning of the study and 1 day and 2 days, 4 days, 7 days and 14 days after the start of the study. Method of measurement: real time PCR.;Lymphocytes count. Timepoint: At the beginning of the study and 1 day and 2 days, 4 days, 7 days and 14 days after the start of the study. Method of measurement: Flowcytometry.;Patients clinical signs. Timepoint: At the beginning of the study and 1 day and 2 days, 4 days, 7 days and 14 days after the start of the study. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Kerman University of Medical Sciences